Tnf Pharmaceuticals, Stock Price on December 5, 2024
| TNFA Stock | 1.36 0.11 7.48% |
Below is the normalized historical share price chart for TNF Pharmaceuticals, extending back to July 24, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of TNF Pharmaceuticals, stands at 1.36, as last reported on the 24th of December, with the highest price reaching 1.49 and the lowest price hitting 1.35 during the day.
If you're considering investing in TNF Stock, it is important to understand the factors that can impact its price. At this point, TNF Pharmaceuticals, is abnormally volatile. TNF Pharmaceuticals, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0051, which indicates the firm had a 0.0051% return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for TNF Pharmaceuticals,, which you can use to evaluate the volatility of the company. Please validate TNF Pharmaceuticals,'s coefficient of variation of 1910.81, and Risk Adjusted Performance of 0.0505 to confirm if the risk estimate we provide is consistent with the expected return of 0.0395%.
At present, TNF Pharmaceuticals,'s Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 19.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 1.1 M. . At present, TNF Pharmaceuticals,'s Price To Sales Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 0.24, whereas Price Earnings Ratio is projected to grow to (0.70). TNF Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of January 2014 | 200 Day MA 3.3706 | 50 Day MA 1.8005 | Beta 2.673 |
TNF |
Sharpe Ratio = 0.0051
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TNFA |
Estimated Market Risk
| 7.72 actual daily | 68 68% of assets are less volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TNF Pharmaceuticals, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TNF Pharmaceuticals, by adding TNF Pharmaceuticals, to a well-diversified portfolio.
Price Book 0.4357 | Book Value (0.02) | Enterprise Value -9.5 M | Shares Float 2.2 M | Shares Outstanding 2.4 M |
Related Headline
Rand Capital Headline on 5th of December 2024
Rand Capital Corporation Declares 4.20 per Share Stock and C... by finance.yahoo.com
BUFFALO, N.Y., December 05, 2024--Rand Capital Corporation Declares 4.20 per Share Stock and Cash Dividend for Fourth Quarter 2024
TNF Pharmaceuticals, Valuation on December 5, 2024
It is possible to determine the worth of TNF Pharmaceuticals, on a given historical date. On December 5, 2024 TNF was worth 1.2 at the beginning of the trading date compared to the closed value of 1.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of TNF Pharmaceuticals, stock. Still, in general, we apply an absolute valuation method to find TNF Pharmaceuticals,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of TNF Pharmaceuticals, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against TNF Pharmaceuticals,'s related companies.
| Open | High | Low | Close | Volume | |
| 1.10 | 1.22 | 1.10 | 1.21 | 64,619 | |
12/05/2024 | 1.20 | 1.27 | 1.16 | 1.22 | 41,822 |
| 1.24 | 1.25 | 1.21 | 1.24 | 37,761 |
| Backtest TNF Pharmaceuticals, | | | TNF Pharmaceuticals, History | | | TNF Pharmaceuticals, Valuation | Previous | Next |
TNF Pharmaceuticals, Trading Date Momentum on December 5, 2024
| On December 06 2024 TNF Pharmaceuticals, was traded for 1.24 at the closing time. The top price for the day was 1.25 and the lowest listed price was 1.21 . The trading volume for the day was 37.8 K. The trading history from December 6, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 1.64% . The trading price change against the current closing price is 5.74% . |
TNF Pharmaceuticals, Fundamentals Correlations and Trends
By evaluating TNF Pharmaceuticals,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among TNF Pharmaceuticals,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. TNF financial account trend analysis is a perfect complement when working with valuation or volatility modules.About TNF Pharmaceuticals, Stock history
TNF Pharmaceuticals, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TNF is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TNF Pharmaceuticals, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TNF Pharmaceuticals, stock prices may prove useful in developing a viable investing in TNF Pharmaceuticals,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.5 M | 1.1 M |
TNF Pharmaceuticals, Stock Technical Analysis
TNF Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
TNF Pharmaceuticals, Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
TNF Pharmaceuticals, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
TNF Pharmaceuticals, December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how TNF Pharmaceuticals, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TNF Pharmaceuticals, shares will generate the highest return on investment. By undertsting and applying TNF Pharmaceuticals, stock market strength indicators, traders can identify TNF Pharmaceuticals, entry and exit signals to maximize returns
TNF Pharmaceuticals, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TNF Pharmaceuticals,'s price direction in advance. Along with the technical and fundamental analysis of TNF Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TNF to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0505 | |||
| Jensen Alpha | 0.4185 | |||
| Total Risk Alpha | 0.1732 | |||
| Sortino Ratio | 0.0516 | |||
| Treynor Ratio | (0.71) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |